Drug factory · FDA FEI 3030495702
Granules Life Sciences Private Limited
Survey No. No. 325, 326, 333 To 336, 340 To 346 Lalgadimalakpet, Shameerpet Medchal-Malkajgiri, India
Problems found, fixed voluntarily at FDA's last inspection, Dec 19, 2025.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
1 drug inspection on record since 2025: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Gabapentin | Makes it, tests it, packages it and labels it | Granules Pharmaceuticals Inc. | 70010-926, 70010-927, 70010-928 |
| Ibuprofen | Makes it, tests it, packages it and labels it | Granules Pharmaceuticals Inc. | 70010-066, 70010-067, 70010-068 |
| Metformin | Makes it, tests it, packages it and labels it | Granules India Limited, Granules Pharmaceuticals Inc. | 62207-440, 62207-441, 62207-442 +3 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Dec 19, 2025 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack.